Caveats of Mesenchymal Stem Cell Therapy in Solid Organ Transplantation|
The authors address the potential pitfalls for the use of mesenchymal stem cells (MSCs) as a therapeutic agent to control alloimmune effects. The aim of this review is not to discourage investigators from clinical studies, but to raise awareness of the intrinsic risks of MSC therapy. [Transpl Int] Abstract
Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field.